The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease

Sutcliffe R, Prior R, Mawby B, McQillan W. Parkinson's disease in the district of Northampton Health Authority, United Kingdom. A study of prevalence and disability.Acta Neurol Scand 1985;72: 363–379.

Ware J, Sherbourne C. The MOS 36 item short form health survey 1: conceptual framework and item selection.Med Care 1992;30: 437–483.

Jenkinson C, Wright L, Coulter A.Quality of life measurement in health care. A review of measures and population norms for the UK SF-36. Oxford, Health Services Research Unit, Oxford University, 1993.

Patrick D, Deyo R. Generic and disease-specific measures in assessing health status and quality of life.Med Care 1989;suppl 27: 217–232.

Guyatt G, Feeny D, Patrick D. Measuring health-related quality of life.Ann Intern Med 1993;118: 622–629.

Cronbach L. Coefficient alpha and the internal structure of tests.Psychometrika 1951;16: 297–334.

Nunnally JC.Psychometric Theory, 2nd edn. New York; McGraw, 1978.

Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.Arthritis Rheum 1985;28: 542–547.

Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality.Neurology 1967;17: 427–442.

Bulpitt C, Shaw K, Clifton P, Stern G, Davies J, Reid J. The symptoms of patients treated for Parkinson's disease.Clin Neuropharmacol 1985;8: 175–183.

Mutch W, Strudwick A, Roy S, Downie A. Parkinson's disease: disability, review and management.Br Med J 1986;293: 675–677.

Shindler J, Brown R, Welburn P, Parkes J. Measuring the quality of life of patients with Parkinson's disease. In: Walker S, Rosser R (eds)Quality of Life: Assessment and Applications Lancaster: MTP Press, 1988.

Welburn P, Walker S. Assessment of quality of life in Parkinson's disease. In Teeling Smith G (ed)Measuring Health: A Practical Approach. London: Wiley, 1988.

Kennard C, Munro A, Park D. The reliability of assessment of Parkinson's disease.J Neurol Neurosurg Psychiat 1984;47: 322–323.

Henderson L, Kennard C, Crawford T, et al. Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity.J Neurol Neurosurg Psychiat 1991;54: 18–24.

Hely M, Wilson A, Williamson P, O'Sullivan D, Rail D, Morris G. Reliability of the Columbia Scale for assessing signs of Parkinson's disease.Movement Disorders 1993;8: 466–474.

Gothan A, Brown R, Marsden C. Depression in Parkinson's disease: a quantitative and qualitative analysis.J Neurol Neurosurg Psychiat 1986;49: 381–389.

Brown R, MacCarthy B, Jahanshahi M, Marsden D. Accuracy of self-reported disability in patients with Parkinsonism.Arch Neurol 1989;46: 955–959.

Dakof G, Mendelsohn G. Patterns of adaptation to Parkinson's disease.Health Psychol 1989;8: 355–372.

Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC. Is essential tremor benign?Neurology 1991;41: 1982–1983.

Longstreth WTJr, Nelson L, Linde M, Munoz D. Utility of the Sickness Impact Profile in Parkinson's disease.J Geriat Psych Neurol 1992;5: 142–148.

Singer E. Social costs of Parkinson's disease.J Chronic Dis 1973;26: 243–254.

Calne D. Treatment of Parkinson's disease.New Engl J Med 1993;329: 1021–1027.

Pentland B, Findley L, Oxtoby M, Pearce V, Quinn N, Scott S. Parkinson's disease: the spectrum of disabilities.J Neurol Neurosurg Psychiat 1992;55 (Suppl): 32–35.

Hopkins A. Clinical audit and neurology.J Neurol Neurosurg Psychiat 1992;55 (Suppl): 19–25.